Media

Vicore Announces Presentations at the European Respiratory Society Congress 2025

Oncopeptides’ rights issue oversubscribed to approximately 157 percent 

Pretzel Therapeutics Strengthens Leadership with Appointment of Ashish Dugar, Ph.D., MBA as Chief Development Officer

Hemab Therapeutics Expands Leadership with Appointment of Anant Murthy, PhD, as Chief Operating Officer

Oncopeptides – New real-world data confirms efficacy and safety of Pepaxti, presented at IMS Annual Meeting

Vicore to Present at Upcoming Investor Conferences

Oncopeptides publishes disclosure document regarding rights issue

Oncopeptides enters into additional guarantee commitments, rights issue fully guaranteed

Positrigo – First University Medical Center in Germany to receive the NeuroLF® system

Oncopeptides carries out rights issue of approximately SEK 150 million and provides update regarding the potential partnership in Japan